Comprehensive services for patients with:
• Esophagus
• Stomach
• Colon, rectum and anus
• Liver
• Gallbladder and bite ducts
• Pancreas
• Sarcomas
Diagnostic and treatment options:
• Upper gastrointestinal endoscopy
• Endoscopic ultrasound
• Colonoscopy and sigmoidoscopy (diagnostic and screening)
• Laparoscopic colon surgery
• Sphincter-preserving surgery for rectal cancer
• Neoadjuvant and postoperative chemotherapy and radiation therapy
• Intraluminal stents
• Radiofrequency ablation of liver tumors
• Hepatic resection
The CDD works in collaboration with the Cancer Center at Boston
Medical Center to offer patients prompt, current and compassionate
care. For upper gastrointestinal malignancies, multidisciplinary
cancer management is critical to the well being of the patient. Our team
|
|
|
|
includes diagnosticians in the areas of radiology, gastroenterology and surgery.
Clinicians in oncologic and gastrointestinal surgery, radiation oncology
and medical oncology provide cancer therapy, as well as access to local and
national clinical trials. We also offer novel treatments such as intraluminal
stents and radiofrequency ablation of liver tumors.
We are known for our expertise in colorectal cancer screening, diagnosis
and treatment. Our screening programs for people who have a high risk of
developing colorectal cancer, as well as those at average risk, integrate
endoscopic strategies with radiological techniques such as virtual
colonoscopy. Genetic counseling is also available for those at risk for developing
hereditary non-polyposis colorectal cancer and familial adenomatous
polyposis. The CDD has extensive experience performing endoscopic
polypectomy, using both standard and advanced techniques such as argon
plasma coagulation (APC) and laser ablation.
Research is currently being conducted on the application of molecular
genetics to the development of new screening strategies for colorectal cancer.
Studies are also being done on the development, implementation and evaluation
of model programs for community-based colorectal cancer control.
|
